Efficacy of Clonidine in Reducing Craving in Inpatients With Cocaine and Crack Use Disorder
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversity of Sao Paulo General Hospital
About this trial
This is a single-center, randomized intervention study in a volunteer population of patients with cocaine/crack use disorder to evaluate the pharmacological treatment of cocaine/crack craving, comparing the drug clonidine with the active placebo clonazepam.
Eligibility criteria
Qualifiers
Patients hospitalized in the adult Alcohol and Drugs ward of the Perdizes Institute (IPer) at the Hospital das Clínicas, University of São Paulo Medical School
DSM-5 criteria for cocaine and/or crack use disorder
Voluntarily seeking treatment
Must be able to swallow pills
Disqualifiers
Inability to read and/or understand the study questionnaires
benzodiazepine use disorder
opioid use disorder
alcohol use disorder
Trial design
Treatments tested in this trial
- clonidine
- clonazepam 0,25 mg
Treatment groups
36 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov